2005
DOI: 10.1016/j.jpedsurg.2005.02.005
|View full text |Cite
|
Sign up to set email alerts
|

Splenic artery embolization in the management of an acute immune thrombocytopenic purpura–related intracranial hemorrhage

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
2

Year Published

2011
2011
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(11 citation statements)
references
References 15 publications
0
9
0
2
Order By: Relevance
“…9 Splenic artery embolization and recombinant activated factor VII was also used successfully in two different cases having CNS bleeding complicating ITP. 10,11 In our case, the patient was complaining of severe headache, vomiting, semiconsciousness requiring emergency treatment. Surprisingly patient's symptoms completely resolved over a period of 15 days after raising the platelet count.…”
Section: Case Reportmentioning
confidence: 76%
“…9 Splenic artery embolization and recombinant activated factor VII was also used successfully in two different cases having CNS bleeding complicating ITP. 10,11 In our case, the patient was complaining of severe headache, vomiting, semiconsciousness requiring emergency treatment. Surprisingly patient's symptoms completely resolved over a period of 15 days after raising the platelet count.…”
Section: Case Reportmentioning
confidence: 76%
“…Puapong et al reported on the successful splenic embolization in a child with intracranial bleeding and persistent thrombocytopenia before neurosurgical management of the intracranial hematoma. 3 From this case it would seem reasonable to embolize the spleen before serious bleeding complications develop. Additionally, Takahashi et al reported their results on five children who had splenic embolization one day before surgical splenectomy.…”
Section: Discussionmentioning
confidence: 94%
“…La esplenectomía es una opción razonable cuando el tratamiento con factores de crecimiento, metrotrexato o rituximab fallan y se necesita una rápida mejoría de la pancitopenia/neutropenia [7][8] . La esplenectomía deriva en una rápida mejoría de la neutropenia en la mayoría de los pacientes 6 .…”
Section: Discussionunclassified